Related Experiment Video
Updated: May 30, 2025

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?
Panteleimon E Papakonstantinou1, José Miguel Rivera-Caravaca2, Mauro Chiarito3
1Atrial Fibrillation Institute, Heart and Vascular Centre, Mater Private Hospital, 71 Eccles St, Dublin 7, D07 WKW8, Dublin 7, Dublin, Ireland; Cardiovascular Research Institute Dublin, Royal College of Surgeons of Ireland, Mater Private Hospital, 71 Eccles St, Dublin 7, D07 WKW8, Dublin 7, Dublin, Ireland.
Insights
Atrial fibrillation (AF) and atrial myopathy both increase stroke risk by promoting clot formation. Understanding their combined impact is key for better thrombogenesis management in high-risk patients.
Area of Science:
- Cardiology
- Thrombosis Research
- Vascular Medicine
Background:
- Atrial fibrillation (AF) and atrial myopathy are linked to cardiovascular disease and stroke.
- AF increases thrombogenesis via irregular heart rhythms and blood stasis.
- Atrial myopathy contributes to thromboembolic events independently of AF.
Purpose of the Study:
- To review the relationship between AF and atrial myopathy in thrombogenesis.
- To discuss epidemiology, risk factors, and clinical implications.
- To explore advancements in antithrombotic therapy and risk assessment.
Main Methods:
- Narrative review of existing literature.
- Analysis of AF burden and stroke risk association.
- Evaluation of atrial myopathy's role in thromboembolism pathogenesis.
Main Results:
- Both AF and atrial myopathy are significant contributors to stroke risk.
- CHA2DS2-VASc score assesses patient risk profiles.
- Current guidelines for anticoagulant therapy are evaluated.
Conclusions:
- A holistic approach to thrombogenesis risk assessment is needed.
- Atrial myopathy is a critical factor in stroke risk, beyond AF alone.
- Future research should focus on novel antithrombotic and anti-inflammatory strategies.
Abstract:
Atrial fibrillation (AF) and atrial myopathy are recognized contributors to cardiovascular morbidity, particularly ischemic stroke. AF poses an elevated risk of thrombogenesis due to irregular heart rhythm leading to blood stasis and clot formation. Atrial myopathy, marked by structural and functional alterations in the atria, is emerging as a crucial factor influencing thromboembolic events, independently of AF. This narrative review article provides an overview of the interwoven relationship between AF and atrial myopathy in thrombogenesis, focusing on the epidemiology, risk factors, and clinical implications of these two entities. The discussion encompasses the association between AF burden and stroke risk, evaluating current evidence and guidelines for anticoagulant therapy. Additionally, it explores the role of atrial myopathy in the pathogenesis of thromboembolic events, emphasizing the patient's clinical profile assessed by the CHA2DS2-VASc score. The manuscript provides insights into ongoing trials and future perspectives, discussing potential advancements in antithrombotic therapy, fibrin clot dynamics, and anti-inflammatory strategies. This comprehensive review challenges the conventional perception of AF as a sole cause of stroke, urging a holistic approach to risk assessment of thrombogenesis and management in the high-risk population that AF patients constitute.
More Related Videos
08:05Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Clot Retraction and Fibrinolysis
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...